Regular biography
Laurent-Dominique Piveteau is a Professor of Practice at École Polytechnique Fédérale de Lausanne, affiliated with the Business / Management department. He is an executive in the life science industry, having served as CEO of Debiotech from 2015 to 2025. Prior to this, he held various positions in R&D and business development. During his PhD thesis, he collaborated with the Robert Mathys Foundation. He worked as a post-doctoral researcher at MIT, focusing on contrast media for MRI, and was involved in technology transfer at EPFL. He co-founded NextKidney, a spin-off of Debiotech, and taught Innovation Economics at EPFL. He is a non-executive director at RSP Systems and Oxyprem AG. He holds an MSc in Physics from ETH Zürich, a PhD from the University of Fribourg, and an MBA from INSEAD.
Scholar-generated biography
Laurent-Dominique Piveteau is a Professor of Practice at EPFL, specializing in the development of advanced coatings and delivery systems for medical applications. His research focuses on creating bioactive and porous coatings for implants, utilizing sol-gel techniques to enhance biocompatibility and mechanical adhesion. He also explores microneedle devices for targeted drug delivery and minimally invasive therapeutic applications. His work includes the design of microfluidic systems and disposable patch pumps for precise drug delivery. Piveteau's research integrates materials science with biomedical engineering to improve patient outcomes through innovative surface engineering and drug delivery technologies.